ClariVest Asset Management’s Emergent Biosolutions EBS Stock Holding History

ClariVest Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-51,724	Closed	-$4.8M	–	773
2021 Q1	$4.8M	Buy	51,724 +15,000	+41%	+$1.54M	0.17%	118
2020 Q4	$3.29M	Sell	36,724 -20,177	-35%	-$1.85M	0.11%	159
2020 Q3	$5.88M	Sell	56,901 -2,452	-4%	-$264K	0.19%	96
2020 Q2	$4.69M	Buy	59,353 +874	+1%	+$65.1K	0.13%	119
2020 Q1	$3.38M	Buy	58,479 +20,979	+56%	+$1.21M	0.1%	131
2019 Q4	$2.02M	Sell	37,500 -24,948	-40%	-$1.35M	0.05%	248
2019 Q3	$3.27M	Sell	62,448 -31,700	-34%	-$1.48M	0.07%	200
2019 Q2	$4.55M	Sell	94,148 -71,600	-43%	-$3.43M	0.1%	170
2019 Q1	$8.37M	Sell	165,748 -8,219	-5%	-$485K	0.17%	128
2018 Q4	$10.3M	Buy	173,967 +26,304	+18%	+$1.7M	0.22%	92
2018 Q3	$9.72M	Sell	147,663 -28,127	-16%	-$1.64M	0.17%	95
2018 Q2	$8.88M	Buy	175,790 +43,689	+33%	+$2.28M	0.15%	121
2018 Q1	$6.96M	Buy	132,101 +8,989	+7%	+$448K	0.12%	148
2017 Q4	$5.72M	Buy	123,112 +38,679	+46%	+$1.63M	0.1%	167
2017 Q3	$3.42M	Buy	84,433 +20,842	+33%	+$754K	0.08%	221
2017 Q2	$2.16M	Sell	63,591 -43	-0.1%	-$1.33K	0.05%	276
2017 Q1	$1.85M	Hold	63,634	–	–	0.05%	289
2016 Q4	$2.09M	Sell	63,634 -62	-0.1%	-$1.86K	0.06%	259
2016 Q3	$2.01M	Sell	63,696 -27,673	-30%	-$804K	0.06%	212
2016 Q2	$2.57M	Buy	91,369 +12,200	+15%	+$478K	0.08%	165
2016 Q1	$2.88M	Sell	79,169 -5,546	-7%	-$196K	0.09%	144
2015 Q4	$3.39M	Sell	84,715 -2,011	-2%	-$70.1K	0.1%	121
2015 Q3	$2.47M	Sell	86,726 -2,000	-2%	-$65.9K	0.07%	163
2015 Q2	$2.92M	Sell	88,726 -7,911	-8%	-$245K	0.09%	157
2015 Q1	$2.78M	Sell	96,637 -1,126	-1%	-$32.3K	0.08%	146
2014 Q4	$2.66M	Sell	97,763 -480	-0.5%	-$11.4K	0.09%	123
2014 Q3	$2.09M	Buy	98,243 +3,606	+4%	+$82.6K	0.08%	170
2014 Q2	$2.13M	Sell	94,637 -22,878	-19%	-$533K	0.08%	169
2014 Q1	$2.97M	Buy	117,515 +79,635	+210%	+$2.01M	0.12%	120
2013 Q4	$871K	Buy	+37,880	New	+$790K	0.04%	230